Filtros de búsqueda

Lista de obras de

Author Correction: Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy

artículo científico publicado en 2020

BRAF Mutant NSCLC and Immune Checkpoint Inhibitors: Results From a Real-World Experience

artículo científico publicado en 2019

Bolus fluorouracil and leucovorin with oxaliplatin as first-line treatment in metastatic colorectal cancer

artículo científico publicado en 2002

Efficacy of nivolumab in pre-treated non-small-cell lung cancer patients harbouring KRAS mutations

FOLFOX4/XELOX in stage II-III colon cancer: Early survival data of the Italian three or six colon adjuvant (TOSCA) trial

artículo científico publicado en 2017

Genetic markers for toxicity of adjuvant oxaliplatin and fluoropyrimidines in the phase III TOSCA trial in high-risk colon cancer patients

artículo científico publicado en 2014

Immune-related adverse events correlate with clinical outcomes in NSCLC patients treated with nivolumab: The Italian NSCLC expanded access program

scientific article published on 20 December 2019

Impact of second-line cetuximab-containing therapy in patients with KRAS wild-type metastatic colorectal cancer: results from the ITACa randomized clinical trial

artículo científico publicado en 2017

Italian Cohort of Nivolumab Expanded Access Program in Squamous Non-Small Cell Lung Cancer: Results from a Real-World Population

scientific article published on 17 April 2019

Italian Nivolumab Expanded Access Program in Nonsquamous Non–Small Cell Lung Cancer Patients: Results in Never-Smokers and EGFR-Mutant Patients

article

Italian cohort of nivolumab Expanded Access Programme (EAP): Preliminary data from a real-world population

artículo científico publicado en 2016

Negative prognostic factors and resulting clinical outcome in patients with metastatic renal cell carcinoma included in the Italian nivolumab-expanded access program

article

Ovarian Sertoli-Leydig cell tumor, endometrioid-like yolk sac tumor, and Y-chromosomal material.

artículo científico publicado en 2003

Real-life results from the overall population and key subgroups within the Italian cohort of nivolumab expanded access program in non-squamous non-small cell lung cancer

scientific article published on 28 October 2019

Real-world efficacy and safety of nivolumab in previously-treated metastatic renal cell carcinoma, and association between immune-related adverse events and survival: the Italian expanded access program

article

Safety and efficacy of nivolumab for metastatic renal cell carcinoma (mRCC): Real world data from an Italian expanded access program (EAP)

article

Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real-world results from an expanded access programme

artículo científico publicado en 2018

Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy

scientific article published on 08 August 2019

Use of nivolumab in elderly patients with advanced squamous non-small-cell lung cancer: results from the Italian cohort of an expanded access programme

article

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda